Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2008-05-20
2008-05-20
Seaman, D. Margaret (Department: 1625)
Organic compounds -- part of the class 532-570 series
Organic compounds
Heterocyclic carbon compounds containing a hetero ring...
C546S163000
Reexamination Certificate
active
07375227
ABSTRACT:
The invention relates to novel 1-pyridin-4-yl urea derivatives and related compounds and their use as active ingredients in the preparation of pharmaceutical compositions. The invention also concerns related aspects including processes for the preparation of the compounds, pharmaceutical compositions containing one or more of those compounds and especially their use as neurohormonal antagonists.
REFERENCES:
patent: 0 428 434 (1991-05-01), None
patent: WO 99/21835 (1999-05-01), None
patent: WO 01/09088 (2001-02-01), None
patent: WO 01/45694 (2001-06-01), None
patent: WO-01/45700 (2001-06-01), None
patent: WO-01/45711 (2001-06-01), None
patent: WO 01/66143 (2001-09-01), None
patent: WO 02/02530 (2002-01-01), None
patent: WO 02/47687 (2002-06-01), None
patent: WO 02/058702 (2002-08-01), None
patent: WO 02/078641 (2002-10-01), None
patent: WO 02/078707 (2002-10-01), None
patent: WO 02/079155 (2002-10-01), None
patent: WO 02/079188 (2002-10-01), None
Ames, R.S., et al.,Nature(1999), 401, pp. 282-286.
Barlin G.B., et al.,Aust. J. Chem. (1984), 37, pp. 1065-1073.
Bern H.A., et al.,Recent Prog. Horm. Res. (1985), 41, pp. 533-552.
Breu V., et al.,FEBS Lett. (1993), 334, pp. 210-214.
Douglas S.A., et al.,Br. J. Pharmacol. (2000), 131, pp. 1262-1274.
Douglas S.A., et al., J.Cardiovasc. Pharmacol. (2000), 36, Suppl.1, pp. S163-S166.
Gartlon J., et al.,Psychopharmacology(Berlin) (2001), 155, pp. 426-433.
Irving H., et al.,J. Chem. Soc. (1959), p. 288.
Kaneko C., et al.,Chem. Pharm. Bull. (1980), 28, pp. 1157-1171.
Laguzza B.C., et al.,Tetrahedron Lett. (1981), 22, pp. 1483-1486.
Liu Q., et al.,Biochem. Biophys. Res. Commun. (1999), 266, pp. 174-178.
Mori M., et al.,Biochem. Biophys. Res. Commun. (1999), 265, pp. 123-129.
Radinov R., et al.,Synthesis(19 86), pp. 886-891.
Russell F.D. et al.,Br. J. Pharmacol. (2001), 132, pp. 5-9.
Silvestre R.A., et al.,Horm. Metab. Res. (2001), 33, pp. 379-381.
Takahashi K., et al.,Peptides(2001), 22, pp. 1175-1179.
Totsune K., et al.,Lancet(2001), 358, pp. 810-811.
Tsandis A., et al.,J. Am. Coll. Cardiol. (2001), 37, p. 164A.
Zou Y., et al.,FEBS Lett. (2001), 508, pp. 57-60.
Aissaoui Hamed
Binkert Christoph
Clozel Martine
Mathys Boris
Mueller Claus
Actelion Pharmaceuticals Ltd.
Seaman D. Margaret
LandOfFree
Quinoline derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Quinoline derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Quinoline derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2811223